Prudential Financial’s Sana Biotechnology SANA Stock Holding History

Prudential Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Buy	29,785 +4,520	+18%	+$14.6K	﹤0.01%	2335
2026 Q1	$72.8K	Buy	+25,265	New	+$99.5K	﹤0.01%	2269
2025 Q4	–	Sell	-16,860	Closed	-$59.9K	–	2411
2025 Q3	$59.9K	Sell	16,860 -1,400	-8%	-$5.06K	﹤0.01%	2323
2025 Q2	$49.9K	Buy	+18,260	New	+$37.7K	﹤0.01%	2346
2024 Q2	–	Sell	-13,350	Closed	-$134K	–	2772
2024 Q1	$134K	Buy	+13,350	New	+$100K	﹤0.01%	2504

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Prudential Financial's SANA Position: Q2 2026 in Review

Prudential Financial increased its Sana Biotechnology (SANA) stake by 18% in Q2 2026, buying an estimated $14.6K and bringing the position to 29,785 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

Prudential Financial first reported a position in SANA in Q1 2024 and has held it in 5 quarters since. The position peaked at $134K in Q1 2024. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Prudential Financial held 29,785 shares of Sana Biotechnology worth $104K as of Q2 2026.
Prudential Financial bought 4,520 Sana Biotechnology shares in Q2 2026, an estimated $14.6K.
Sana Biotechnology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2335 holding.
Prudential Financial first reported a position in Sana Biotechnology in Q1 2024 and has held it in 5 quarters since.
Prudential Financial's Sana Biotechnology position peaked at $134K in Q1 2024.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.